- Student Records
Programme & Unit Catalogues

Department of Pharmacy & Pharmacology, Unit Catalogue 2011/12


PA50202: Neurology

Click here for further information Credits: 6
Click here for further information Level: Masters UG & PG (FHEQ level 7)
Click here for further information Period: Modular (no specific semester)
Click here for further information Assessment: CW 60%, OR 40%
Click here for further information Supplementary Assessment: Like-for-like reassessment (where allowed by programme regulations)
Click here for further information Requisites:
Click here for further information Description: Aims:
This clinical module aims to update pharmacists on neurological disorders and patient monitoring factors that should be considered when providing pharmaceutical care for these patients.

Learning Outcomes:
By the end of the unit the student will be able to:
1. Describe and analyse the role of the healthcare professional / pharmacist in prescribing and monitoring medication for patients with neurological disease (knowledge and understanding).
2. Explain the disease and patient monitoring factors that are influenced in this therapeutic area (knowledge and understanding, professional practical skill).
3. Critically evaluate the evidence base and medicines management issues for treatment of neurological disease and be able to present this information to your peer group (intellectual skill).
4. Reflect on their own practice in prescribing and medicines management issues for these patients and identify areas for continuous improvement (personal transferable skill).

Skills:

* Planning & organisation (Taught/Facilitated)
* Handling information (Taught/Facilitated)
* Written communication (Taught/Facilitated/Assessed)
* Working with others (Taught/Facilitated)
* Scientific & practical skills (Taught/Facilitated/Assessed)
* Improving learning & performance (Taught/Facilitated)
* Information & communication technology (ICT) (Taught/Facilitated/Assessed)
* Problem solving (Taught/Facilitated).

Content:

* Unit Introduction
* Stroke
* Parkinson's Disease I
* Parkinson's Disease II
* Epilepsy
* Drug therapy in Epilepsy
* Neurological Disorders I
* Neurological Disorders II.
Click here for further informationProgramme availability:

PA50202 is Optional on the following programmes:

Department of Pharmacy & Pharmacology
  • TSPA-ADT16 : Modular Programme in Advanced and Specialist Practice (Distance Learning)
  • TSPA-ADM16 : MSc Advanced and Specialist Healthcare Practice (Distance Learning)
  • TSPA-ADM10 : MSc Clinical Pharmacy Practice (Primary Care) (Distance Learning)
  • TSPA-ADM07 : MSc Clinical Pharmacy Practice (Secondary Care) (Distance Learning)
  • TSPA-ADM12 : MSc Prescribing & Therapeutics (Distance Learning)
  • TSPA-ADC16 : PG Cert Advanced and Specialist Healthcare Practice (Distance Learning)
  • TSPA-ADC12 : PG Cert Clinical Pharmacy Practice (Primary Care) (Distance Learning)
  • TSPA-ADC09 : PG Cert Clinical Pharmacy Practice (Secondary Care) (Distance Learning)
  • TSPA-ADC14 : PG Cert Medicines Management (Distance Learning)
  • TSPA-ADC15 : PG Cert Prescribing & Therapeutics (Distance Learning)
  • TSPA-ADL16 : PG Dip Advanced and Specialist Healthcare Practice (Distance Learning)
  • TSPA-ADL11 : PG Dip Clinical Pharmacy Practice (Primary Care) (Distance Learning)
  • TSPA-ADL08 : PG Dip Clinical Pharmacy Practice (Secondary Care) (Distance Learning)
  • TSPA-ADL12 : PG Dip Prescribing & Therapeutics (Distance Learning)

NB. Programmes and units are subject to change at any time, in accordance with normal University procedures.